中医肿瘤重点学科关键问题及创新发展  

Key Issues and Innovative Development in the Key Discipline of Traditional Chinese Medicine Oncology

作　　者：中华中医药学会肿瘤分会 花宝金 侯炜 张兴 郑红刚 贾英杰 周蕾 张恩欣 刘瑞 郭秋均 元润智 张曦文 Oncology Branch of Chinese Assoclation of Chinese Medicine

机构地区：[1]不详

出　　处：《中医杂志》2025年第3期222-227,共6页Journal of Traditional Chinese Medicine

基　　金：国家中医药管理局中医药创新团队及人才支持计划项目(ZYYCXTD-C-202205);中国中医科学院科技创新工程项目(CI2021B009);中华中医药学会学科发展报告系列研究(肿瘤分会)。

摘　　要：中医肿瘤重点学科在理论体系的建立与发展、临床疗效研究、机制探讨、人才培养、团队建设、学术组织与联盟发展等方面均取得显著成果,但存在现有临床疗效证据仍欠充分、具有疗效优势的中药新药研发还需加强、中医药防治肿瘤的机制阐释有待深入、中医肿瘤科研体系建设需继续完善、科研能力应进一步提升等问题。故提出加强中医药防治肿瘤的高质量循证研究、中医药防治肿瘤产品的品牌建设、中医肿瘤重点学科科研关键技术体系构建、高维度中医肿瘤重点学科理论守正创新、国家级中医肿瘤创新支撑平台搭建5大攻关方向,并以科技创新为核心的新质生产力推动中医肿瘤重点学科高质量发展。The key discipline of traditional Chinese medicine(TCM)oncology has achieved remarkable results in the establishment and development of theoretical systems,clinical efficacy research,mechanism exploration,talent cultivation,team building,and the growth of academic organizations and alliances.However,there remain problems such as lack of sufficient clinical evidence,improvement of the development of new TCM drugs with efficacy advantages,further elucidation of the mechanisms underlying TCM-based tumor prevention and treatment,and enhan-cement of the research system for TCM oncology and research capabilities.Therefore,this paper proposes five criti-cal directions,including advancing high-quality evidence-based research on TCM for tumor prevention and treat-ment,building brand recognition for TCM-based anti-tumor products,establishing key technological systems for TCM oncology research,ensuring theoretical innovation and continuity in TCM oncology,and creating a national-level inno-vation platform to support TCM oncology.By prioritizing scientific and technological innovation as the core of new pro-ductive forces,the high-quality development of TCM oncology as a key discipline can be further promoted.

关 键 词：中医肿瘤重点学科 学科建设 肿瘤防治 理论创新 临床疗效 

分 类 号：R273[医药卫生—中西医结合]